Myocardial infarction. Acute myocardial infarction
Conditions
Interventions
Intervention 1: Intervention (colchicine) group: they will receive the drug as 1 mg oral capsule during chest pain (in chest pains last less than 24 hours) and 0.5 mg 1 hour later and then 0.5 mg onc
Treatment - Drugs
Placebo
Intervention (colchicine) group: they will receive the drug as 1 mg oral capsule during chest pain (in chest pains last less than 24 hours) and 0.5 mg 1 hour later and then 0.5 mg once a day for 5 da
Placebo group: they will receive the drug as 1 mg placebo oral capsule during chest pain (in chest pains last less than 24 hours) and 0.5 mg 1 hour later and then 0.5 mg once a day for 5 days.
Sponsors
Vice chancellor for research, Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having a diagnosis of STEMI; being at the age of 18-80 years. Exclusion criteria: pregnancy; heart failure; heart surgery; renal failure; anemia; thrombocytopenia; using colchicine in last 3 days; allergy to colchicine; using macrolides, cyclosporine or tolbutamide.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ejection Fraction. Timepoint: In the second day of admission, before discharge. Method of measurement: Echocardiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Adineh
Zahedan University of Medical Sciences
Outcome results
None listed